SciELO - Scientific Electronic Library Online

 
vol.58 issue2Efficacy of the intradomiciliary treatments with cypermethrin, lamdda-cyhalothrin and chlorpyrifos insecticides in an Aedes aegypti strainRecognition of intact cells from Cryptococcus neoformans by the anti-glucuronoxylomannan 4B3 monoclonal antibody author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Medicina Tropical

On-line version ISSN 1561-3054

Abstract

MARCET SANCHEZ, Ricardo; FIGUEREDO PINO, Mabel  and  SARRACENT PEREZ, Jorge. Monoclonal antibody mimicking the structure of an immunoprotective epitope against Fasciola hepatica. Rev Cubana Med Trop [online]. 2006, vol.58, n.2, pp. 0-0. ISSN 1561-3054.

The ES-78 monoclonal antibodiy recognizes excretory-secretory antigens of Fasciola hepatica. This monoclonal antibody is used for diagnosis of humans and cattle fasciolosis. The production of 4 anti-idiotype monoclonal antibodies (3G5, 5G1, 3H4 and 1H6) inhibiting the antigen-monoclonal antibody ES 78 reaction was reported. This antibody recognizes excretion-secretion antigens of Fasciola hepatica and it is used for the diagnosis in faeces of fascioliasis in the bovine cattle and in humans. When the 3G5 was used in rabbits as an immunogen there was a response of antibodies against the excretion-secretion antigen of Fasciola hepatica without a previous contact wih it. The utilization of this anti-idiotype monoclonal antibody as an immunogen mimmicking a protective epitope against fascioliasis together with appropriate adjuvants may be a new way of reducing the parasitic burden in experimental models of fascioliasis.

Keywords : Fasciola hepatica; monoclonal antibody ES-78; anti-idiotype monoclonal antibodies; parasitic vaccines.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License